SCFAs such as butyrate produced by the digestive tract bacterial processing of dietary fiber reduces the development of inflammatory and metabolic disorders in humans and improved insulin sensitivity concurrent with increased energy expenditure in murine diet-induced obesity [33, 35]. This evidence concerns the gene INS and metabolic disease.